Wiley Bros.-aintree Capital »

Prime Medicine shares owned by Wiley Bros.-aintree Capital

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Wiley Bros.-aintree Capital from 13F filings

Historical chart of Wiley Bros.-aintree Capital investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Wiley Bros.-aintree Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $71k 12k 5.96

More positions owned by Wiley Bros.-aintree Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr Msci Usa Qlt Fct (QUAL)

View all positions for Wiley Bros.-aintree Capital

Top funds holding Prime Medicine

Alphabet
T. Rowe Price Investment Management
BlackRock
ARK Investment Management
Vanguard Group
Farallon Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
D. E. Shaw & Co
MWG Management
Geode Capital Management

View all funds holding Prime Medicine